Clinical trial
Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.
NCT00242047 · University of Cape Town, Other · Unknown status
Key facts
| NCT number | NCT00242047 |
|---|---|
| Title | Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination. |
| Official title | Randomized, Controlled Trial Comparing Efficacy of Percutaneous and Intradermal Vaccination With Japanese (Tokyo) 172 BCG in the Prevention of Tuberculosis In Infants Vaccinated at Birth |
| Lead sponsor | University of Cape Town, Other |
| Collaborators | Aeras Japan BCG Laboratory 4-2-6 Kohinata,Tokyo 112-0006, Japan. |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Biological |
| Interventions | Japanese (Tokyo) 172 Bacille Calmette Guerin (BCG). |
| Enrollment | 12,000 |
| Start date | Mar 1, 2001 |
| Completion | Aug 1, 2006 |
| First posted | Oct 19, 2005 |
| Last update posted | Oct 19, 2005 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: